Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Methadone Stories

2014-04-09 23:03:38

Opiate abuse is growing quickly in the Tampa area. Millennium Treatment Group is seeing an influx of patients with an addiction to opiates and can offer a great treatment option to help the community. Lake Worth, FL (PRWEB) April 09, 2014 Opiate addiction is on the rise in the Tampa area. Millennium Treatment Group has seen a recent increase in the number of patients needing treatment. Because of this, Millennium Treatment Group is offering a great addiction treatment option for those in...

2014-04-09 16:25:15

Part One: "Treating Pain in Today's World: Avoiding the New Pitfalls" LOS ANGELES, April 9, 2014 /PRNewswire/ -- The Cooperative of American Physicians, Inc. (CAP) and The Orange County Medical Association (OCMA) are joint sponsors of "Treating Pain in Today's World: Avoiding the New Pitfalls," the first topic in a three part continuing medical education (CME) series on opioid education. This topic will be presented on Monday, May 5, 2014 at 6 p.m. PT at the Orange County Medical Association...

2014-04-09 08:28:50

Dr. Sarah Bagley to be honored at American Society of Addiction Medicine Conference SAN DIEGO and ORLANDO, Fla., April 9, 2014 /PRNewswire/ -- Millennium Research Institute (MRI) today announced Dr. Sarah Bagley, a fellow in addiction medicine in the Section of General Internal Medicine at Boston University Medical Center in Boston, as the inaugural recipient of the American Society of Addiction Medicine (ASAM) and Millennium Research Institute Research Fellowship Award, which...

2014-04-09 08:28:09

HOUSTON, April 9, 2014 /PRNewswire/ -- There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can frontline practitioners do to meet the challenges of this growing public health issue? Attend PAINWeekEnd Houston! The 2014 PAINWeekEnd Regional Conference convenes on Saturday, May 10, in Houston at the Marriott Houston Westchase. Now entering its 4(th) year,...

2014-04-08 20:21:36

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved prescription drug product, Zohydro(TM) ER (hydrocodone bitartrate) extended-release capsules (CII), entered on March 27, 2014, by Massachusetts Governor Deval Patrick. Zogenix appreciates the opportunity to be heard by the court on an expedited basis. A follow-up hearing has been...

2014-04-08 12:31:56

New Partnership Extends the National Representation of Focused Pain Relief Transdermal Compounded Medications VICTOR, N.Y., April 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief--customized transdermal compounded medications for pain and inflammation--announced today that the company has entered into a partnership with RS Medical of Vancouver, Wash. In this partnership, RS Medical will be providing services to educate and support physicians in their...

2014-04-07 08:30:13

RICHMOND, Va., April 7, 2014 /PRNewswire/ -- Kaleo (formerly Intelliject) today announced that it has entered into a $150 million debt facility with PDL BioPharma (NASDAQ: PDLI) to enable kaleo to support commercialization of EVZIO(TM)(naloxone hydrochloride injection) and development of key pipeline products. Under the financing, PDL provided $150 million in cash at closing and will receive interest on the principal outstanding. The note is backed by royalty payments on kaleo's first...

2014-04-07 08:29:44

--Questcor Shareholders Receive $30.00 in Cash and 0.897 Mallinckrodt Shares for Each Share of Questcor Common Stock They Own-- DUBLIN and ANAHEIM, Calif., April 7, 2014 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuticals company, and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a high-growth biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction...

2014-04-04 23:38:27

Pleio Health Support Systems released new data from its GoodStart adherence program demonstrating that 41% more patients achieved a PDC (Proportion of Days Covered) medication adherence rate of at least 80% which is the threshold for patients to be considered highly adherent to their medications. Tampa Bay, FL (PRWEB) April 03, 2014 Pleio Health Support Systems released new data from its GoodStart adherence program for hypertensive patients. The analysis was conducted on patients with...

2014-04-04 08:24:45

-- Clinically meaningful improvement in quality of life with single injection of resiniferatoxin SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that investigators from the National Institutes of Health (NIH) presented data highlighting results from the first two dosing cohorts of the Phase I/II trial of...